pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
DCC-3009
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals Inc
0
catalysts
Phase 1
DF-6002
Cervical Cancer
Dragonfly Therapeutics Inc
0
catalysts
Phase 1
DFP-11207
Gastric Cancer
Delta-Fly Pharma Inc
0
catalysts
Preclinical
DHA-dFdC
Leukemia
← prev
page 17 of 62
next →
131
Pain
89
Neurology
1
AIkido Labs Inc
0
catalysts
Phase 1
DIACC-3010
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Evexta Bio SA
0
catalysts
Phase 1
DM-002
Solid Tumor
Doma Biopharmaceutical (Suzhou) Co Ltd
0
catalysts
Phase 1
DM-919
Solid Tumor
D2M Biotherapeutics Ltd
0
catalysts
Preclinical
DMR-001
Essential Thrombocythemia
$DMRA
Damora Therapeutics, Inc.
0
catalysts
Preclinical
DPH-008
Prostate Cancer
Disruptive Pharma AB
0
catalysts
Preclinical
DPH-00X
Unspecified Cancer
Disruptive Pharma AB
0
catalysts
Phase 2
DPTX-3186
Gastric Cancer
Dewpoint Therapeutics Inc
0
catalysts
Phase 1
DS-1103
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
Integral Molecular Inc
0
catalysts
Phase 1
DS-2243
Solid Tumor
Daiichi Sankyo Co Ltd
0
catalysts
Phase 2
DS-3939
Solid Tumor
Daiichi Sankyo Co Ltd
0
catalysts
Phase 1
DS-5361
Head And Neck Squamous Cell Carcinoma (HNSC)
Daiichi Sankyo Co Ltd
0
catalysts
Phase 1
DS-9051
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Daiichi Sankyo Co Ltd
0
catalysts
Phase 2
DSP-107
Colorectal Cancer
KAHR medical Ltd
0
catalysts
Preclinical
DUET-101
Bladder Cancer
Duet Therapeutics Inc
0
catalysts
Phase 1
DVX-201
Myelodysplastic Syndrome (Preleukemia)
$COEP
Coeptis Therapeutics Holdings, Inc.
0
catalysts
Phase 2
DX-126262
Gastric Cancer
Hangzhou DAC Biotech Co Ltd
0
catalysts
Phase 2
Decoy-20
Adenoid Cystic Carcinoma (ACC)
$INDP
Indaptus Therapeutics, Inc.
0
catalysts
Phase 1
Deltacel
Non-Small Cell Lung Cancer
Immunocell Therapeutics Inc
0
catalysts
Phase 1
Diakine-DK210 (EGFR)
Bladder Cancer
Deka Biosciences Inc
0
catalysts
Preclinical
DisPATCH
Solid Tumor
RootPath Genomics Inc
0
catalysts
Marketed
Doxorubicin Teva
Doxorubicin Hydrochloride (doxorubicin)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Teva Pharmaceuticals USA Inc
0
catalysts
Preclinical
Drug to Inhibit MDM2 for Retinoblastoma
Retinoblastoma
Spectocular LLC
0
catalysts
Preclinical
Drugs for Oncology
Pancreatic Ductal Adenocarcinoma
SRI International
0
catalysts
Phase 1
E-7766
Solid Tumor
Eisai Co Ltd
0
catalysts
Phase 2
EB-103
B-Cell Non-Hodgkin Lymphoma
$ESLA
Estrella Immunopharma, Inc.
0
catalysts
Preclinical
EB-104
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$ESLA
Estrella Immunopharma, Inc.
0
catalysts
